House committee questions Biogen drug approval process
December 30, 2022 at 00:08 AM EST
The FDA's approval process of Biogen's Alzheimer's drug was questioned in a Congressional report released Thursday.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.